[11C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide Receptor

被引:19
作者
Bell, Ian M. [1 ]
Gallicchio, Steven N. [1 ]
Stump, Craig A. [1 ]
Bruno, Joseph G. [4 ]
Fan, Hong [3 ]
Gantert, Liza T. [3 ]
Hostetler, Eric D. [3 ]
Kemmerer, Amanda L. [4 ]
McWherter, Melody [1 ]
Moore, Eric L. [2 ]
Mosser, Scott D. [4 ]
Purcell, Mona L. [3 ]
Riffel, Kerry [3 ]
Salvatore, Christopher A. [2 ]
Sanabria-Bohorquez, Sandra [3 ]
Staas, Donnette D. [1 ]
White, Rebecca B. [6 ]
Williams, Mangay [3 ]
Zartman, C. Blair [1 ]
Cook, Jacquelynn J. [3 ]
Hargreaves, Richard J. [5 ]
Kane, Stefanie A. [2 ]
Graham, Samuel L. [1 ]
Selnick, Harold G. [1 ]
机构
[1] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA
[2] Merck Res Labs, Dept Pain & Migraine, West Point, PA 19486 USA
[3] Merck Res Labs, Dept Imaging, West Point, PA 19486 USA
[4] Merck Res Labs, Dept In Vitro Pharmacol, West Point, PA 19486 USA
[5] Merck Res Labs, Dept Neurosci & Ophthalmol, West Point, PA 19486 USA
[6] Merck Res Labs, Dept Pharmacokinet Pharmacodynam & Drug Metab, West Point, PA 19486 USA
关键词
MK-4232; calcitonin gene-related peptide receptor; positron emission tomography; CGRP; ANTAGONIST; MIGRAINE; POTENT; DISCOVERY;
D O I
10.1021/ml400199p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Rational modification of the potent calcitonin gene-related peptide (CGRP) receptor antagonist MK-3207 led to a series of analogues with enhanced CNS penetrance and a convenient chemical handle for introduction of a radiolabel. A number of C-11-tracers were synthesized and evaluated in vivo, leading to the identification of [C-11](8) ([C-11]MK-4232), the first positron emission tomography tracer for the CGRP receptor.
引用
收藏
页码:863 / 868
页数:6
相关论文
共 20 条
[1]   MK-8825: A potent and selective CGRP receptor antagonist with good oral activity in rats [J].
Bell, Ian M. ;
Stump, Craig A. ;
Gallicchio, Steven N. ;
Staas, Donnette D. ;
Zartman, C. Blair ;
Moore, Eric L. ;
Sain, Nova ;
Urban, Mark ;
Bruno, Joseph G. ;
Calamari, Amy ;
Kemmerer, Amanda L. ;
Mosser, Scott D. ;
Fandozzi, Christine ;
White, Rebecca B. ;
Zrada, Matthew M. ;
Selnick, Harold G. ;
Graham, Samuel L. ;
Vacca, Joseph P. ;
Kane, Stefanie A. ;
Salvatore, Christopher A. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) :3941-3945
[2]   Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist [J].
Bell, Ian M. ;
Gallicchio, Steven N. ;
Wood, Michael R. ;
Quigley, Amy G. ;
Stump, Craig A. ;
Zartman, C. Blair ;
Fay, John F. ;
Li, Chi-Chung ;
Lynch, Joseph J. ;
Moore, Eric L. ;
Mosser, Scott D. ;
Prueksaritanont, Thomayant ;
Regan, Christopher P. ;
Roller, Shane ;
Salvatore, Christopher A. ;
Kane, Stefanie A. ;
Vacca, Joseph P. ;
Selnick, Harold G. .
ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (01) :24-29
[3]   BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study [J].
Diener, Hans-Christoph ;
Barbanti, Piero ;
Dahloef, Carl ;
Reuter, Uwe ;
Habeck, Julia ;
Podhorna, Jana .
CEPHALALGIA, 2011, 31 (05) :573-584
[4]   Inhibition of calcitonin gene-related peptide function: A promising strategy for treating migraine [J].
Durham, Paul L. .
HEADACHE, 2008, 48 (08) :1269-1275
[5]  
Eckelman WC., 1979, Principles of radiopharmacology, P251
[6]   CGRP Receptor Antagonism and Migraine [J].
Edvinsson, Lars ;
Ho, Tony W. .
NEUROTHERAPEUTICS, 2010, 7 (02) :164-175
[7]   Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine [J].
Hewitt, David J. ;
Aurora, Sheena K. ;
Dodick, David W. ;
Goadsby, Peter J. ;
Ge, Yang ;
Bachman, Robert ;
Taraborelli, Donna ;
Fan, Xiaoyin ;
Assaid, Christopher ;
Lines, Christopher ;
Ho, Tony W. .
CEPHALALGIA, 2011, 31 (06) :712-722
[8]   CGRP and its receptors provide new insights into migraine pathophysiology [J].
Ho, Tony W. ;
Edvinsson, Lars ;
Goadsby, Peter J. .
NATURE REVIEWS NEUROLOGY, 2010, 6 (10) :573-582
[9]   Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial [J].
Ho, Tony W. ;
Ferrari, Michel D. ;
Dodick, David W. ;
Galet, Vince ;
Kost, James ;
Fan, Xiaoyin ;
Leibensperger, Heather ;
Froman, Samar ;
Assaid, Christopher ;
Lines, Christopher ;
Koppen, Hille ;
Winner, Paul K. .
LANCET, 2008, 372 (9656) :2115-2123
[10]  
Hostetler E., 2009, 6 ANN WORLD MOL IM C